GAP treatment resulted ... and gallbladder cancer, though not statistically significant. The study emphasizes the need for genomic and AI tools to guide targeted therapies in BTCs, acknowledging tumor ...

MSD’s PD-1 inhibitor Keytruda has been approved by the FDA as a treatment for locally advanced unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy, the first ...